ArticleMethods in molecular biology (Clifton, N.J.)2027
Experimental Repression Targeting Long Noncoding RNAs (lncRNAs) Using an Antisense Oligonucleotide (ASO) Technology in Primary Human Epidermal Keratinocytes.
Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epidermal keratinocytes, the major cell type of the epidermis, undergo a well-orchestrated balance between proliferation and differentiation, which is essential for proper skin function. While the related control processes have been studied at the protein-coding gene level, increasing evidence highlights the importance of long noncoding RNAs (lncRNAs) in regulating gene expression and cell fate decisions. LncRNAs constitute a large proportion of the human transcriptome; however, the biological functions of most of them remain poorly characterized. Emerging studies demonstrate that lncRNAs play critical roles in cellular identity, differentiation, and tissue homeostasis. In the epidermis, several lncRNAs have been shown to regulate keratinocyte behavior, showing the importance of lncRNAs in epidermal biology and skin homeostasis. Multiple strategies have been developed to study lncRNA functions, including RNA interference (RNAi) and CRISPR-based approaches. However, these methods often show limited efficiencies to reach nuclear transcripts or may introduce confounding genomic effects. Antisense oligonucleotides (ASOs) provide a particularly effective technological option by inducing RNase H-mediated degradation of target transcripts and enabling rapid, reversible, and transcript-specific knockdown without any modification of genomic DNA. Together, these considerations highlight the use of ASOs as a powerful and appropriate approach to investigate the functional roles of lncRNAs in epidermal keratinocytes and to better understand their contribution to cell fate regulation in the skin. Here we describe an optimized protocol for ASO transfection in primary human epidermal keratinocytes cells in order to efficiently knock down specific lncRNA targets. The expression level of the transcripts was quantified using a ddPCR quantitative approach. As a proof of concept, we repressed the expression of the lncRNA LINC02154 in keratinocytes using three different ASOs. This ASO-based approach offers a reliable and versatile platform for functional interrogation of nuclear lncRNAs in epidermal keratinocytes and facilitates deeper understanding of lncRNA-mediated regulation of skin cell fate.
Indexed as
Identifiers
41872415What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.